Pharmacy

A new survey from Express Scripts has surprisingly findings about medication adherence in patients with chronic diseases.

A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.

A new study investigates the impact of interruptions in the emergency room. Here are the disturbing results

The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.

How skipping industry acronyms and jargon and using simple terminology will eliminate confusion and misinterpretation.

A Surescripts survey reveals the need for more interoperable access to patient data in three major areas.

An ONC report finds that more patients are engaged with their health records. Here’s why.

The goal is to help ensure that prescription drug marketing information for consumers and healthcare providers is truthful and balanced. Here’s what the agency plans to research.

Drug makers and payers have these challenges to implement outcomes-based contracts, but here are three steps that can be taken as a transition toward these payment arrangements.

A new report is making some healthcare executives a bit more optimistic about efforts to curb the opioid epidemic. Find out why.

A new program shows promise for improving patient medication adherence. Find out how it works.

Here are three innovative structures in pricing models to address the high-cost of curative therapies.

Here's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.

Attending the AMCP Managed Care and Specialty Pharmacy Annual Meeting in Boston April 23 to April 26? Here are our top session recommendations.

A study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.

Diabetes drug spending is on the rise, but there are ways to control it.

A new Oliver Wyman study reveals costly findings about Part D beneficiaries enrolled in plans without preferred pharmacy networks.

We know you’re pressed for time, so we’re here to help. Listen to this two-minute podcast for critical takeaways from three of our top articles.